Complex organic molecules speed development of new drugs

Professor Varinder Aggarwal is no ordinary builder. He and his team in the School of Chemistry have just discovered a new technique that could hasten the development of new drugs for today’s incurable diseases – by building complex organic molecules.

Complex organic molecules are finding increasing applications in virtually all aspects of our lives, from the pill we take for heart disease and the insecticide used in the production of the food we eat, to the flat screens of mobile phones. However, the science of creating complex organic molecules, known as organic synthesis, is exacting. It requires years of training to master the principles and then, rather like building an enormous cathedral, many years to assemble the building blocks into the required molecule. So why is organic synthesis so hard?

Organic synthesis involves the piecing together of smaller organic building blocks until the target molecule is created, but this process is not as simple as putting one row of bricks on top of another. In organic synthesis the two ends of the building blocks first have to be activated in some way to make them attracted to each other so they can bond together. Once bonded, this new molecule is used in another reaction with a different building block, a process which is repeated again and again until the target molecule is formed.

However, as the molecule increases in size and complexity it becomes more and more difficult to activate only the site you want, without other sites being activated as well. As a result, unwanted compounds are formed in addition to the desired molecule. So the molecule has to be extracted from the mixture before the next step of activation and attachment of another building block can occur.

As the starting molecule passes down the assembly line, building blocks are added sequentially with extraordinary precision

The breakthrough Aggarwal and his team of molecular chemists have made is that they have found a way of activating particular building blocks with complete selectivity for a particular site. More importantly, the product formed is ready-primed for reaction with the next building block without the need for further activation. This avoids the arduous task of selectively activating an increasingly complex molecule at a specific site; it is already done through some clever chemical gymnastics.

They have also shown that complex molecules can be created by repeated addition of these building blocks in a process analogous to a molecular assembly line. As the starting molecule passes down the assembly line, building blocks are added sequentially with extraordinary precision so that at the end of the process a complex molecule is created with specific shape and functionality.

It is hoped that the molecular assembly-line process can ultimately be automated so that complex organic molecules with specific architectures and functions can be created simply by pressing a few buttons.

These exciting new developments are enabling a technology with a potentially huge impact. Furthermore, they open up the scientific discipline of organic synthesis from the limited confines of the expert to a much broader pool of scientists. Physicists, molecular biologists and all the disciplines in between will no longer be limited in their scientific quest by molecules they can buy off the shelf – they will be limited only by their imaginations.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder